PALI实时信号 | 通过Getagraph.com最大化利润

购买 109133 min ago

@ $0.419

发出时间: 13 Feb 2024 @ 23:41

回报率: 1 344.26%

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	266 852
平均成交量	934 018
市值	73.39M
EPS	$0 ( 2024-03-27 )
下一个收益日期	( $-4.80 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	18.91
ATR14	$0.0440 (0.72%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	Finley John David	Buy	5 558	Common Stock, par value $0.01
2024-03-11	Finley John David	Sell	5 558	Restricted Stock Units
2024-02-09	Neal James R	Buy	12 160	Common Stock Options
2024-02-09	Neal James R	Buy	5 820	Common Stock, par value $0.01
2024-02-09	Neal James R	Buy	6 880	Common Stock Options

INSIDER POWER
33.99
Last 100 transactions
Buy: 569 716 \| Sell: 281 847

音量相关性

長: 0.33 (neutral)

短: 0.53 (weak)

Signal:(49.547) Neutral

Palisade Bio, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Palisade Bio, Inc. 相关性 - 货币/商品

0.14
( neutral )

0.39
( neutral )

0.00
( neutral )

-0.12
( neutral )

-0.05
( neutral )

-0.33
( neutral )

Palisade Bio, Inc. 财务报表

Annual	2022
营收:	$0
毛利润:	$-167 000 (0.00 %)
EPS:	$-14.54

FY	2022
营收:	$0
毛利润:	$-167 000 (0.00 %)
EPS:	$-14.54

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-109.92

FY	2020
营收:	$13 520.00
毛利润:	$13 520.00 (100.00 %)
EPS:	$-293.16

Financial Reports:

No articles found.

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.